Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

While this subjective cognitive decline (SCD) linked to menopause tends to be transient, it can often occur at an age when ...

At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s ...

The establishment of the ERAS protocols catalyses the changes in the IV treatment settings and highlights the need for a ...

The new first-line MCL indication gives Calquence a slice of the market of its own and could spur further growth of the drug, ...

As a result of the disappointing results, Boehringer said that it was abandoning a long-term extension trial called CONNEX-X, ...

In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...

In Part 3 of our Life Sciences Industry Report 2025, we share content from the last twelve months that delved into the ...

The FDA has banned the use of a synthetic red dye used in oral medicines, as well as foods and dietary supplements, more than ...